Influence of Alcohol and Peer Passengers on Risky Driving Behavior in Young Adults

January 23, 2018 updated by: Marie Claude Ouimet, Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Among the many risk factors that contribute to young drivers' crash involvement, two are critical: peer passenger presence, which is unique to young drivers, and the influence of alcohol, a universal risk for drivers but one against which young drivers are most susceptible. Clarification of how passenger presence interacts with alcohol consumption to increase risk is needed. The impact of experimentally manipulated passenger characteristics and alcohol quantity on risky driving is observed using driving simulation and a random assignment experimental design with a sample of 18-21 year old male and female drivers.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

240

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Longueuil, Quebec, Canada, J4K 0A8
        • Université de Sherbrooke

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 21 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • being 18 to 21 years of age (18 years old is the legal age for alcohol consumption in the province of Quebec)
  • past experirence with drinking at least 2 alcoholic beverages in one episode
  • having a provisional driving license
  • driving in the past 3 months

Exclusion Criteria:

  • health problem that contraindicates participation
  • pregnant or breastfeeding
  • signs of problem drinking
  • positive BAC or recent drug use measured at arrival

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: no alcohol and passenger
Blood alcohol concentration (BAC) = 0.00% and risk accepting or averse passenger
Driving with risk accepting or risk averse passenger
Experimental: low alcohol dose and passenger
BAC = 0.02% and risk accepting or averse passenger
Driving with risk accepting or risk averse passenger
Experimental: moderate alcohol dose and passenger
BAC = 0.05% and risk accepting or averse passenger
Driving with risk accepting or risk averse passenger

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Risky driving in a simulator
Time Frame: within 1 hr after alcohol dose
within 1 hr after alcohol dose

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marie Claude Ouimet, Ph.D., Université de Sherbrooke

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2011

Primary Completion (Actual)

June 3, 2015

Study Completion (Actual)

June 3, 2015

Study Registration Dates

First Submitted

May 5, 2012

First Submitted That Met QC Criteria

May 8, 2012

First Posted (Estimate)

May 10, 2012

Study Record Updates

Last Update Posted (Actual)

January 25, 2018

Last Update Submitted That Met QC Criteria

January 23, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • MOP-111034

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Accidents, Traffic

Clinical Trials on Passenger

3
Subscribe